Skip to main content

Ranking Vaccines A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System (2013) / Chapter Skim
Currently Skimming:

Appendix E: Stakeholder Speakers
Pages 125-126

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 125...
... Agency for International Development ­PHILIP ECKHOFF, Research Scientist and Principal Investigator, Disease Modeling Team, Intellectual Ventures ­ IRENE ECKSTRAND, Scientific Officer, Models of Infectious Disease Agent Study, National Institute of General Medical Sciences, National Institutes of Health ­RAINER ENGELHARDT, Assistant Deputy Minister, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada ­ALEXANDER GARZA, Assistant Secretary for Health Affairs and Chief Medical Officer, Department of Homeland Security ­ANN GINSBERG, Vice President, Scientific Affairs, Aeras ­MARION GRUBER, Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration ­DAVID HAMMER, Product Manager, Joint Vaccine Acquisition Program, Chemical Biological Medical Systems, Department of Defense ­CAROLE HEILMAN, Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health 125
Read the entire page →
From page 126...
... 126 RANKING VACCINES: A Prioritization Software Tool ­­SETH HETHERINGTON, Chief Medical Officer, Genocea Biosciences; Member, National Vaccine Advisory Committee ­JOACHIM HOMBACH, Senior Adviser, Department of Immunisation, Vaccines and Biologicals, World Health Organization ­PETER HOTEZ, President, Albert Sabin Vaccine Institute, and Dean, National School of Tropical Medicine, Baylor College of Medicine ROBERT KOLODNER, Chief Health Informatics Officer and Acting Executive Officer, Open Health Tools ­PRASAD KULKARNI, Medical Director, The Serum Institute of India Limited ­DIANA LANCHONEY, Executive Director, Vaccine Ventures and New Products, Merck & Company ­TIMOTHY LANT, Director, Analytic Decision Support, Biomedical Advanced Research and Development Authority, Department of Health and Human Services ­OSMAN MANSOOR, Senior Health Advisor, New Vaccines, United Nations Children's Fund ­RICHARD MARTINELLO, Chief Consultant, Clinical Public Health, Department of Veterans Affairs ­GENEVIEVE MEIER, Health Economics Manager, North America Vaccines Division, GlaxoSmithKline Vaccines CHRISTOPHER MURRAY, Director, Institute for Health Metrics and Evaluation, University of Washington School of Medicine ­ALEX PALACIOS, Special Representative, GAVI Alliance ­PATRICIA QUINLISK, Medical Director, Iowa Department of Health ­ROBIN ROBINSON, Director, Biomedical Advanced Research and Development Authority, Department of Health and Human Services ­JEFFREY STURCHIO, Senior Partner, Rabin Martin MELINDA WHARTON, Deputy Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
Read the entire page →

Key Terms

  • medical officer
  • alexander garza
  • irene eckstrand
  • intellectual ventures
  • deputy minister

  • scientific officer
  • assistant deputy
  • chief medical
  • rainer engelhardt
  • agent study

  • medical sciences
  • disease modeling
  • product manager
  • joint vaccine
  • david hammer

  • health agency
  • vaccine acquisition
  • disease prevention
  • control branch
  • health affairs

  • modeling team
  • public health
  • national institute
  • assistant secretary
  • national institutes

  • biological medical
  • vice president
  • vaccines research
  • principal investigator
  • disease agent


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.